As another new year gets under way, many of us will be looking for a way of boosting how we feel, but is it better to hit the ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

There are hundreds of cell types in the human body, each with a specific role spelled out in their DNA. In theory, all it ...

Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...

Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...

This segment analyzes key limitations of current evidence—including the non-randomized design of PHAROS and challenges of cross-trial comparison—while underscoring the ongoing need for better ...

What separates a good app from a great one? It’s not just functionality, it’s the way users feel when they interact with it. A clunky, inconsistent interface can frustrate users, no matter how ...

The authors sought to understand the differential impact of payer-led community-based care management approaches on stakeholder-oriented outcomes for publicly insured adults with multiple chronic ...

Great AI doesn’t happen in isolation. These UX strategies — from confidence scores to graceful error recovery — turn users into active collaborators. The AI ...

A massive two-year study reveals fitness apps can help people take more steps, but the improvements are modest and uneven—raising big questions about who benefits most and how to make digital health ...

The Washington-based Providence health system has undertaken a rigorous research program, including randomized trials, to understand the impact of new technology deployments internally. Providence ...